Zeynep Idil Seckin1, Joseph R Duffy2, Edythe A Strand2, Heather M Clark2, Rene L Utianski2, Mary M Machulda3, Hugo Botha4, Farwa Ali1, Nha Trang Thu Pham5, Val J Lowe5, Jennifer L Whitwell5, Keith A Josephs6. 1. Department of Neurology, Movement Disorders, Mayo Clinic, Rochester, MN, USA. 2. Department of Neurology, Speech Pathology, Mayo Clinic, Rochester, MN, USA. 3. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. 4. Department of Neurology, Behavioral Neurology, Mayo Clinic, Rochester, MN, USA. 5. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA; Department of Radiology, Mayo Clinic, Rochester, MN, USA. 6. Department of Neurology, Movement Disorders, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Behavioral Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address: josephs.keith@mayo.edu.
Abstract
INTRODUCTION: Primary progressive apraxia of speech (PPAOS) is a neurodegenerative syndrome in which patients present with an isolated motor speech disorder. Some PPAOS patients develop parkinsonism and other features of progressive supranuclear palsy (PSP) and/or corticobasal syndrome (CBS) over time. We aimed to assess the evolution of parkinsonian characteristics in PPAOS patients who had been followed yearly for at least six years. METHODS: From a large cohort of 46 PPAOS patients, eight were followed yearly for > 6-years in multiple NIH-funded grants. Parkinsonian and other features, including bradykinesia, tremor, rigidity, postural instability, apraxia, ocular motor function and cognition were assessed at each visit, and research criteria applied for PSP and CBS diagnosis. Neurological, speech-language test scores, and [18F]fluorodeoxyglucose PET (FDG-PET) and MRI midbrain volumes were assessed. RESULTS: A Parkinson's plus syndrome developed in all eight patients (100%). Bradykinesia was the earliest feature, followed by rigidity and postural instability. Tremor was not a significant feature. Parkinsonism, limb apraxia and ocular motor impairment tended to develop four-to-five years after onset with some patients having slight asymmetric parkinsonism. Six patients (75%) met research criteria for probable PSP, although only one for PSP-Richardson's syndrome; three patients met criteria for possible CBS. Slightly asymmetric, left-sided, hypometabolism was observed on FDG-PET, not matching asymmetry of Parkinsonism. Midbrain hypometabolism was absent-minimal. Three patients had progressive midbrain volumes in the PSP-Richardson's syndrome range. CONCLUSIONS: A Parkinson's plus syndrome may inevitably develop in PPAOS supporting PPAOS as an early presentation of a Parkinson's plus disorder.
INTRODUCTION: Primary progressive apraxia of speech (PPAOS) is a neurodegenerative syndrome in which patients present with an isolated motor speech disorder. Some PPAOS patients develop parkinsonism and other features of progressive supranuclear palsy (PSP) and/or corticobasal syndrome (CBS) over time. We aimed to assess the evolution of parkinsonian characteristics in PPAOS patients who had been followed yearly for at least six years. METHODS: From a large cohort of 46 PPAOS patients, eight were followed yearly for > 6-years in multiple NIH-funded grants. Parkinsonian and other features, including bradykinesia, tremor, rigidity, postural instability, apraxia, ocular motor function and cognition were assessed at each visit, and research criteria applied for PSP and CBS diagnosis. Neurological, speech-language test scores, and [18F]fluorodeoxyglucose PET (FDG-PET) and MRI midbrain volumes were assessed. RESULTS: A Parkinson's plus syndrome developed in all eight patients (100%). Bradykinesia was the earliest feature, followed by rigidity and postural instability. Tremor was not a significant feature. Parkinsonism, limb apraxia and ocular motor impairment tended to develop four-to-five years after onset with some patients having slight asymmetric parkinsonism. Six patients (75%) met research criteria for probable PSP, although only one for PSP-Richardson's syndrome; three patients met criteria for possible CBS. Slightly asymmetric, left-sided, hypometabolism was observed on FDG-PET, not matching asymmetry of Parkinsonism. Midbrain hypometabolism was absent-minimal. Three patients had progressive midbrain volumes in the PSP-Richardson's syndrome range. CONCLUSIONS: A Parkinson's plus syndrome may inevitably develop in PPAOS supporting PPAOS as an early presentation of a Parkinson's plus disorder.
Authors: Ondrej Bezdicek; Filip Růžička; Adela Fendrych Mazancova; Jan Roth; Pavel Dušek; Karsten Mueller; Evžen Růžička; Robert Jech Journal: J Int Neuropsychol Soc Date: 2017-07-18 Impact factor: 2.892
Authors: Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: Katerina A Tetzloff; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Sarah M Boland; Rene L Utianski; Hugo Botha; Matthew L Senjem; Christopher G Schwarz; Keith A Josephs; Jennifer L Whitwell Journal: Neurocase Date: 2018-05-25 Impact factor: 0.881
Authors: Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Anthony J Spychalla; Jeffrey L Gunter; Ronald C Petersen; Clifford R Jack; Keith A Josephs Journal: J Neurol Date: 2015-06-17 Impact factor: 4.849
Authors: Keith A Josephs; Joseph R Duffy; Edyth A Strand; Jennifer L Whitwell; Kenneth F Layton; Joseph E Parisi; Mary F Hauser; Robert J Witte; Bradley F Boeve; David S Knopman; Dennis W Dickson; Clifford R Jack; Ronald C Petersen Journal: Brain Date: 2006-04-13 Impact factor: 13.501
Authors: Rene L Utianski; Joseph R Duffy; Heather M Clark; Edythe A Strand; Sarah M Boland; Mary M Machulda; Jennifer L Whitwell; Keith A Josephs Journal: Am J Speech Lang Pathol Date: 2018-11-21 Impact factor: 2.408
Authors: Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner Journal: Neurology Date: 2013-01-29 Impact factor: 9.910
Authors: Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Ankit V Master; Val J Lowe; Clifford R Jack; Jennifer L Whitwell Journal: Brain Date: 2012-03-01 Impact factor: 13.501
Authors: Fatma Ozlem Hokelekli; Joseph R Duffy; Heather M Clark; Rene L Utianski; Hugo Botha; Farwa Ali; Julie A Stierwalt; Mary M Machulda; R Ross Reichard; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs Journal: Mov Disord Date: 2021-10-10 Impact factor: 10.338
Authors: Rene L Utianski; Peter R Martin; Joseph R Duffy; Hugo Botha; Heather M Clark; Keith A Josephs Journal: Am J Speech Lang Pathol Date: 2021-09-07 Impact factor: 4.018
Authors: Keith A Josephs; Joseph R Duffy; Heather M Clark; Rene L Utianski; Edythe A Strand; Mary M Machulda; Hugo Botha; Peter R Martin; Nha Trang Thu Pham; Julie Stierwalt; Farwa Ali; Marina Buciuc; Matthew Baker; Cristhoper H Fernandez De Castro; Anthony J Spychalla; Christopher G Schwarz; Robert I Reid; Matthew L Senjem; Clifford R Jack; Val J Lowe; Eileen H Bigio; Ross R Reichard; Eric J Polley; Nilufer Ertekin-Taner; Rosa Rademakers; Michael A DeTure; Owen A Ross; Dennis W Dickson; Jennifer L Whitwell Journal: Nat Commun Date: 2021-06-08 Impact factor: 17.694